Sirdalud

Medicinal product

(Invented) name

Sirdalud

Active substance (s)

Tizanidinas

Strength

2 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M03BX02, Tizanidine

Marketing authorisation holder

Sandoz d.d., Slovėnija

Date of authorisation

1994-03-31

Date of renewal

2011-12-21

Documents

0947 Pakuotės lapelis 2024 07 17.docx

0947 Sirdalud tab II PL 2024 07 17.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Tizanidinas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
2193	2204	1002204	lizdinė plokštelė	N30		Receptinis	LT/1/94/0947/001	Netiekiama	2025-04-07	2025-09-16	No	-	-	Download

Stadijos

Data	Stadija
2011-12-21	Perregistruotas
1994-03-31	Registruotas